Exhaled small RNA biomarkers to detect and monitor airway disease
呼出的小 RNA 生物标志物可检测和监测气道疾病
基本信息
- 批准号:10323050
- 负责人:
- 金额:$ 51.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAirway DiseaseAlveolarAnatomyAntibodiesAsthmaAutomationBiological AssayBiological MarkersCell Surface ProteinsChronic Obstructive Pulmonary DiseaseClinicalCollectionDataDetectionDevelopmentDiagnosisDiscriminationDiseaseEarly DiagnosisEarly InterventionElectron MicroscopyEncapsulatedEnvironmentEpithelialExhalationFrequenciesGoalsHumanIndividualIrrigationLungLung diseasesMeasurableMeasurementMessenger RNAMethodsMicroRNAsMolecularMonitorNon-Invasive Cancer DetectionNucleic AcidsOral cavityPatientsPersonsPhasePopulationProspective cohortProspective cohort studyProthrombinQuantitative Reverse Transcriptase PCRRNARNA analysisRecoveryReproducibilityReverse Transcriptase Polymerase Chain ReactionRiskRisk FactorsRoboticsSamplingSignal TransductionSmall RNASmoking HistorySourceSpecificitySpecimenStructure of parenchyma of lungSurfaceTechnologyTestingTissuesValidationWestern BlottingWorkasthmaticbasecase controlclinically relevantearly detection biomarkersexosomeformer smokermicroRNA biomarkersnanoparticlenever smokernext generation sequencingnovelresearch clinical testingsample collectionscale upspecific biomarkerssurrogacytool
项目摘要
ABSTRACT
“Exhaled small RNA biomarkers to detect and monitor airway disease”
Asthma and chronic obstructive pulmonary disease (COPD) together affect over 600 million people worldwide,
highlighting the need for development of novel tools for early diagnosis and intervention. Because airways
communicate directly with the external environment, airway-based sampling provides a unique opportunity to
capture lung disease-specific biomarkers. Therefore, we have opted to interrogate exhaled breath condensate
(EBC), and our multi-lab collaborative team has demonstrated that unfractionated EBC from >500 donors contain
intact microRNAs, measurable by both qPCR and next generation sequencing (NGS). More recently, using an
optimized antibody-based (anti-CD63) purification assay, we identified the presence of small exhaled exosomes
in EBC, confirmed by electron microscopy and nanoparticle tracking, western-blotting, and by small-RNA NGS.
Our pilot clinical analyses of exhaled-exosomes specimens suggest that our unique approach may allow
detection of significant asthma and COPD case-control discriminant signals, using qualitative and quantitative
RT-PCR. The next phase of our work is to technically refine the combined applicability of our optimized molecular
approaches, and to evaluate the identification of asthma/COPD-specific exhaled biomarkers at diagnosis and at
exacerbation, testing airway tissue-specific antibodies to select exhaled exosomes for analyses. In this R33
proposal, we hypothesize that the: Optimized recovery and quantification of EBC-derived small-RNA
biomarkers will advance non-invasive airway (asthma, COPD) disease case-control discrimination and
disease monitoring, beyond existing technology. For these NGS and qPCR small-RNA analyses and
validations, we will compare exhaled whole and exosome-partitioned EBC samples, select internal references,
cross-validate detection/quantification methods, and confirm airway level of origin of EBC biomarkers. We will
develop refined small/microRNA panels via NGS and qPCR, and introduce automation platforms for higher
throughput evaluation of clinical specimens in two case-control pilots. The primary impact of this R33 project will
be to refine the development of exhaled small/miRNA biomarkers for asthma and COPD detection, with intent to
identify early exacerbation discriminators. This study will establish the basis for a multi-institutional prospective
cohort validation for exhaled small nucleic acid biomarkers for these two common lung disorders.
摘要
“呼出的小RNA生物标志物用于检测和监测气道疾病”
哮喘和慢性阻塞性肺疾病(COPD)共同影响全世界超过6亿人,
强调需要开发新的早期诊断和干预工具。因为航空公司
直接与外部环境沟通,基于气道的采样提供了一个独特的机会,
捕获肺部疾病特异性生物标志物。因此,我们选择询问呼出气体冷凝物
(EBC)我们的多实验室合作团队已经证明,来自>500名供体的未分级EBC含有
完整的microRNA,可通过qPCR和下一代测序(NGS)测量。最近,使用
优化的基于抗体(抗CD 63)的纯化试验,我们确定了呼出的小外泌体的存在
在EBC中,通过电子显微镜和纳米颗粒跟踪、蛋白质印迹和小RNA NGS证实。
我们对呼出外泌体标本的初步临床分析表明,我们独特的方法可能允许
使用定性和定量方法检测显著的哮喘和COPD病例对照判别信号
RT-PCR法我们工作的下一个阶段是从技术上完善我们优化的分子的组合适用性,
方法,并评估在诊断时和治疗期间识别哮喘/COPD特异性呼出生物标志物,
急性加重,测试气道组织特异性抗体以选择呼出的外泌体用于分析。在这款R33
我们假设:优化EBC衍生的小RNA的回收和定量
生物标志物将促进非侵入性气道(哮喘、COPD)疾病病例对照鉴别,
疾病监测,超越现有技术。对于这些NGS和qPCR小RNA分析,
为了验证,我们将比较呼出的完整和外泌体分区的EBC样品,选择内部参考,
交叉验证检测/定量方法,并确认EBC生物标志物来源的气道水平。我们将
通过NGS和qPCR开发精细的小/microRNA面板,并引入自动化平台,
在两个病例对照试点的临床标本的吞吐量评价。该R33项目的主要影响将是
将完善用于哮喘和COPD检测的呼出小/miRNA生物标志物的开发,目的是
识别早期恶化鉴别器。这项研究将为多机构的前景奠定基础
这两种常见肺部疾病的呼出小核酸生物标志物的队列验证。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV-CATCHER): A customizable purification assay designed for small-RNA biomarker identification and evaluation of circulating small-EVs.
- DOI:10.1002/jev2.12110
- 发表时间:2021-06
- 期刊:
- 影响因子:16
- 作者:Mitchell MI;Ben-Dov IZ;Liu C;Ye K;Chow K;Kramer Y;Gangadharan A;Park S;Fitzgerald S;Ramnauth A;Perlin DS;Donato M;Bhoy E;Manouchehri Doulabi E;Poulos M;Kamali-Moghaddam M;Loudig O
- 通讯作者:Loudig O
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Olivier Loudig其他文献
Olivier Loudig的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Olivier Loudig', 18)}}的其他基金
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
患有导管原位癌的女性随后发生浸润性乳腺癌风险的分子标记
- 批准号:
10227721 - 财政年份:2017
- 资助金额:
$ 51.57万 - 项目类别:
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
患有导管原位癌的女性随后发生浸润性乳腺癌风险的分子标记
- 批准号:
9981666 - 财政年份:2017
- 资助金额:
$ 51.57万 - 项目类别:
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
患有导管原位癌的女性随后发生浸润性乳腺癌风险的分子标记
- 批准号:
9753182 - 财政年份:2017
- 资助金额:
$ 51.57万 - 项目类别:
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
患有导管原位癌的女性随后发生浸润性乳腺癌风险的分子标记
- 批准号:
9854635 - 财政年份:2017
- 资助金额:
$ 51.57万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 51.57万 - 项目类别:
Directed Grant